Lo, A <br/><br/>
Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation.  [electronic resource] 

 -  Transplantation proceedings   
 - 1701-3 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/s0041-1345(00)02649-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Basiliximab<br/>Daclizumab<br/>Drug Therapy, Combination<br/>Female<br/>Glucocorticoids--therapeutic use<br/>Graft Rejection--prevention & control<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Transplantation--immunology<br/>Male<br/>Mycophenolic Acid--analogs & derivatives<br/>Pancreas Transplantation--immunology<br/>Prednisone--therapeutic use<br/>Receptors, Interleukin-2--immunology<br/>Recombinant Fusion Proteins<br/>Survival Rate<br/>Tacrolimus--therapeutic use